[HTML][HTML] Role of Hox genes in stem cell differentiation
A Seifert, DF Werheid, SM Knapp… - World journal of stem …, 2015 - ncbi.nlm.nih.gov
Hox genes are an evolutionary highly conserved gene family. They determine the anterior-
posterior body axis in bilateral organisms and influence the developmental fate of cells …
posterior body axis in bilateral organisms and influence the developmental fate of cells …
Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia
Infant B-cell acute lymphoblastic leukemia (B-ALL) accounts for 10% of childhood ALL. The
genetic hallmark of most infant B-ALL is chromosomal rearrangements of the mixed-lineage …
genetic hallmark of most infant B-ALL is chromosomal rearrangements of the mixed-lineage …
[HTML][HTML] Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis
A Agraz-Doblas, C Bueno, R Bashford-Rogers… - …, 2019 - ncbi.nlm.nih.gov
B-cell acute lymphoblastic leukemia is the commonest childhood cancer. In infants, B-cell
acute lymphoblastic leukemia remains fatal, especially in patients with t (4; 11), present in …
acute lymphoblastic leukemia remains fatal, especially in patients with t (4; 11), present in …
Mouse models of MLL leukemia: recapitulating the human disease
TA Milne - Blood, The Journal of the American Society of …, 2017 - ashpublications.org
Chromosome translocations involving the mixed lineage leukemia (MLL) gene fuse it in
frame with multiple partner genes creating novel fusion proteins (MLL-FPs) that cause …
frame with multiple partner genes creating novel fusion proteins (MLL-FPs) that cause …
[HTML][HTML] Instructive role of MLL-fusion proteins revealed by a model of t (4; 11) pro-B acute lymphoblastic leukemia
Summary The t (4; 11)(q21; q23) fuses mixed-lineage leukemia (MLL) to AF4, the most
common MLL-fusion partner. Here we show that MLL fused to murine Af4, highly conserved …
common MLL-fusion partner. Here we show that MLL fused to murine Af4, highly conserved …
Molecular processes involved in B cell acute lymphoblastic leukaemia
C Malouf, K Ottersbach - Cellular and molecular life sciences, 2018 - Springer
B cell leukaemia is one of the most frequent malignancies in the paediatric population, but
also affects a significant proportion of adults in developed countries. The majority of infant …
also affects a significant proportion of adults in developed countries. The majority of infant …
HOXA9 promotes hematopoietic commitment of human embryonic stem cells
V Ramos-Mejía, O Navarro-Montero… - Blood, The Journal …, 2014 - ashpublications.org
The molecular determinants regulating the specification of human embryonic stem cells
(hESCs) into hematopoietic cells remain elusive. HOXA9 plays a relevant role in …
(hESCs) into hematopoietic cells remain elusive. HOXA9 plays a relevant role in …
Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation
Increasing evidence supports that mesenchymal stromal/stem cells (MSCs) may represent
the target cell for sarcoma development. Although different sarcomas have been modeled in …
the target cell for sarcoma development. Although different sarcomas have been modeled in …
Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors
Human induced pluripotent stem cells (hiPSC) have been generated from different tissues,
with the age of the donor, tissue source and specific cell type influencing the reprogramming …
with the age of the donor, tissue source and specific cell type influencing the reprogramming …
Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9
KA Secker, H Keppeler, S Duerr-Stoerzer, H Schmid… - Oncogene, 2019 - nature.com
MLL rearrangements play a crucial role in leukemogenesis and comprise a poor prognosis.
Therefore, new treatment strategies are urgently needed. We used the CRISPR/Cas9 …
Therefore, new treatment strategies are urgently needed. We used the CRISPR/Cas9 …